logo
Maryland lawmakers call President Trump's "big, beautiful bill" a betrayal

Maryland lawmakers call President Trump's "big, beautiful bill" a betrayal

CBS News04-07-2025
Maryland Democratic lawmakers expressed disappointment after President Donald Trump's budget bill passed Congress.
The so-called "big, beautiful bill" is expected to be signed into law by the president on Friday, July 4.
The Maryland Freedom Caucus, headed by Congressman Andy Harris, said the bill "secured transformational wins for fiscal responsibility, border security, energy independence, welfare reform, and tax relief."
What's included in the "big, beautiful bill?"
Mr. Trump's budget bill was approved in a 218 to 214 vote by the House, and a 51-50 vote in the Senate, which required Vice President JD Vance to be the tiebreaker.
The bill, when signed, would make significant cuts to healthcare and nutrition programs, like Medicaid and SNAP. According to CBS News, the bill would add $3.4 trillion to federal deficits over the next 10 years and leave millions without health insurance.
The legislation includes more than $46.5 billion for border wall construction and related expenses, $45 billion to expand detention capacity for immigrants in custody, and about $30 billion in funding for hiring, training, and other resources for U.S. Immigration and Customs Enforcement, CBS News reports.
The package also includes an increase to the cap on the state and local tax deduction, raising it from $10,000 to $40,000, according to CBS News. After five years, it would return to $10,000, a departure from the initial House-passed bill.
CBS News says the bill would raise the debt ceiling by $5 trillion, going beyond the $4 trillion outlined in the initial House-passed bill.
And, the current $2,000 child tax credit is set to return to the pre-2017 level of $1,000 in 2026, according to CBS News, and the tax credit would permanently increase to $2,200 under the bill, $300 less than the initial House-passed hike.
Maryland lawmakers react to the passed budget bill
Democrats in Congress voted against the bill unanimously, citing steep cuts to safety net programs, including SNAP, the food assistance program, and Medicaid.
Lawmakers in Maryland argue that the bill provides for the rich and takes away from those who need the assistance.
"This so-called 'Big Beautiful Bill' marks a direct and heartless assault on the American people," Maryland Gov. Wes Moore said in a statement. "Neither Maryland nor any other state across the country has the resources to fill the massive hole that the federal government created today in our social safety net."
Gov. Moore called the bill a nightmare for Maryland families, saying it impacts healthcare for senior citizens, student loan borrowers, those relying on food assistance, and people with disabilities.
"President Trump and Republicans in Congress are cutting a quarter of a billion dollars from Maryland's rural hospitals, taking health care away from nearly 200,000 Marylanders, and hurting 684,000 Marylanders that rely on food assistance to pay for their groceries—working families, seniors, children, veterans, homeless individuals and people with disabilities. Today, our federal government has delivered a gift to the ultra-wealthy and told everyone else: 'You're on your own,'" Gov. Moore said.
This so-called 'Big Beautiful Bill' marks a direct and heartless assault on the American people. Neither Maryland nor any other state across the country has the resources to fill the massive hole that the federal government created today in our social safety net.
My full… pic.twitter.com/s0b8m2Hrz1 — Governor Wes Moore (@GovWesMoore) July 3, 2025
Baltimore City Mayor Brandon Scott called the bill a "bad policy" and a "betrayal."
"Every member of Congress who voted for this should be ashamed. Baltimore won't forget," Scott said.
The mayor said the legislation threatens jobs, healthcare access, and public safety, and makes it easier to purchase guns.
"For cities like Baltimore, the impact will be devastating," Scott said.
This is an ugly bill-cruel, reckless, and deeply out of touch with the needs of everyday Americans. This isn't just bad policy-it's a betrayal. And every member of Congress who voted for this should be ashamed. Baltimore won't forget. pic.twitter.com/qjJk32Uiip — Brandon M. Scott (@MayorBMScott) July 3, 2025
Maryland Sen. Chris Van Hollen criticized Republicans in Congress for backing Mr. Trump over the U.S. citizens, and called it "tax breaks for billionaires."
"A giant handout for the ultra-rich. A big, ugly betrayal for everyone else," Van Hollen said.
Once again Rs in Congress put Trump before their constituents — voting for tax breaks for billionaires while cutting Medicaid, food and clean energy programs, and adding a whopping $4.2T to the debt.
A giant handout for the ultra-rich. A big, ugly betrayal for everyone else. https://t.co/eg29BvUyWv — Senator Chris Van Hollen (@ChrisVanHollen) July 3, 2025
Maryland Sen. Angela Alsobrooks added that it is a "dark day for America."
"Republicans have slashed health care for Americans with disabilities, taken food from the mouths of hungry children, and left our seniors to fend for themselves."
A dark day for America.
Republicans have slashed health care for Americans with disabilities, taken food from the mouths of hungry children, and left our seniors to fend for themselves.
It's a disgrace. https://t.co/b9udRnrE8Q — Senator Angela Alsobrooks (@Sen_Alsobrooks) July 3, 2025
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Yahoo

time11 minutes ago

  • Yahoo

[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Paracetamol Market size & share revenue was valued at approximately USD 876.48 Million in 2024 and is expected to reach USD 922.41 Million in 2025 and is expected to reach around USD 1460.23 Million by 2034, at a CAGR of 5.24% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Johnson & Johnson, GlaxoSmithKline, Pfizer Inc., Novartis AG, Dr. Reddy's Laboratories Ltd., Aspen Pharmacare, Adcock Ingram, Julphar (Gulf Pharmaceutical Industries), Ache Laboratories Pharmaceutics, EMS Pharma, Hikma Pharmaceuticals, Bharat Chemicals, Farmson Pharmaceuticals, SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation), Mylan N.V. (now part of Viatris) and others. Austin, TX, USA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled 'Paracetamol Market Size, Trends and Insights By Product Type (Tablet, Capsule, Liquid Suspension, Powder), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application Type (Headache & Fever, Muscle Cramps, Cold & Cough), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' in its research database. 'According to the latest research study, the demand of the global Paracetamol Market size & share was valued at approximately USD 876.48 Million in 2024 and is expected to reach USD 922.41 Million in 2025 and is expected to reach a value of around USD 1460.23 Million by 2034, at a compound annual growth rate (CAGR) of about 5.24% during the forecast period 2025 to 2034.' Click Here to Access a Free Sample Report of the Global Paracetamol Market @ Overview As per the industry experts at CMI, the paracetamol market is expected to witness a linear CAGR during the forecast period. This could be attributed to steadiness on the part of demand for paracetamol globally. Paracetamol is being used as an antipyretic and analgesic, especially in fever and pain relief medications. The market is further catalyzed by growing healthcare awareness, increasing incidences of chronic conditions, and a rising aging population worldwide. Key Trends & Drivers Growing Incidences of Fever and Pain to Determine Growth: Ailments such as flu, headaches, arthritis, and post-operative pain are reported to be managed using paracetamol. Rising incidences on their part do directly translate into a higher demand for medication. The consumers are also increasingly developing awareness about OTC medications such as paracetamol and do prefer treating minor illnesses on their own, thereby driving its usage further. Request a Customized Copy of the Paracetamol Market Report @ Increased Usage in Surgical Applications to Catalyze the Paracetamol Market: IV paracetamol is increasingly preferred due to its ability to effectively manage moderate to severe pain without side effects linked with opioids, such as constipation and nausea. It makes provision for quicker pain relief in comparison with oral medications, thereby making it the most sought-after medication post-surgery. Report Scope Feature of the Report Details Market Size in 2025 USD 922.41 Million Projected Market Size in 2034 USD 1460.23 Million Market Size in 2024 USD 876.48 Million CAGR Growth Rate 5.24% CAGR Base Year 2024 Forecast Period 2025-2034 Key Segment By Product Type, Distribution Channel, Application Type and Region Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America Buying Options Request tailored purchasing options to fulfil your requirements for research. (A free sample of the Paracetamol report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the following: Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report. The COVID-19 Pandemic Outbreak Impact Analysis is included in the package. About 220+ Pages Research Report (Including Recent Research) Provide detailed chapter-by-chapter guidance on the Request. Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2025 Includes Tables and figures have been updated. The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Custom Market Insights (CMI) research methodology (Please note that the sample of the Paracetamol report has been modified to include the COVID-19 impact study prior to delivery.) Request a Customized Copy of the Paracetamol Market Report @ SWOT Analysis Strengths: Paracetamol is easily accessible OTC in various forms such as capsules, tablets, and liquids. It is comparatively inexpensive, thereby rendering it cost-effective for a wider consumer base. Plus, it is one of the common ingredients in various fever-reducing and pain relief products and is used for treating conditions such as muscle aches, headaches, and the common cold. Rising occurrences of lifestyle-oriented ailments are the catalysts to paracetamol market. Weaknesses: Improper dosage or overuse could cause damage to the liver. Additionally, the reliance of the market on API production in certain regions is likely to create vulnerabilities pertaining to the supply chain. Furthermore, the market is bound to face fierce competition from the manufacturers of generic medicines, which could reduce the market share of established players and reduce their overall profitability. Opportunities: Researching and developing paracetamol-based products for specified pain conditions such as migraines are likely to unlock novel market segments. Also, exploration of the use of paracetamol in conjunction with the other drugs for improved pain relief and the other therapeutic advantages could provide lucrative opportunities to the paracetamol market. Threats: Negative publicity around the safety concerns related to paracetamol is likely to negatively affect the consumers' demand and perception. Also, Volatility of costs of raw materials used in the production of paracetamol could adversely affect profitability and production costs. Emergence of newer combinations of pain management solutions could also cut down on market share. Request a Customized Copy of the Paracetamol Market Report @ Key questions answered in this report: What is the size of the Paracetamol market and what is its expected growth rate? What are the primary driving factors that push the Paracetamol market forward? What are the Paracetamol Industry's top companies? What are the different categories that the Paracetamol Market caters to? What will be the fastest-growing segment or region? In the value chain, what role do essential players play? What is the procedure for getting a free copy of the Paracetamol market sample report and company profiles? Key Offerings: Market Share, Size & Forecast by Revenue | 2025−2034 Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions Competitive Landscape – Top Key Vendors and Other Prominent Vendors Buy this Premium Paracetamol Research Report | Fast Delivery Available - [220+ Pages] @ Regional Perspective The paracetamol market is divided into North America, Europe, Asia Pacific, and LAMEA. North America North America leads the paracetamol market, and the status quo is expected to remain unchanged during the forecast period. This is credited to rising incidences of migraines, headaches, and fever all across the U.S. The American Migraine Foundation states that the year 2020 witnessed the presence of over 4 million adults in the U.S. battling chronic daily migraine, that too, with close to 15 headaches per month. The government is also handsomely investing in research regarding therapeutics for chronic pain. As per the May 2022 update from the NIH (National Institute of Health), the government of the U.S. did spend USD 689 Million and USD 725 Million in 2020 and 2021 respectively in this regard. Europe Europe is expected to hold a significant share of the paracetamol market owing to an increase in healthcare spending on the part of the governments. The tropical regions are prone to year-round influenza, which is fueling the market therein. The EU has set stringent regulatory standards for various pharmaceuticals (inclusive of paracetamol), which ascertain safety and quality. Asia Pacific Asia Pacific is expected to witness the highest CAGR in the paracetamol market during the forecast period. This could be due to a rise in the population suffering from the common cold, cough, fever, and migraine. China and India are the major manufacturers of paracetamol APIs. They are thus paving the way for cost-effective supply chains. LAMEA Individuals in LAMEA are gaining more awareness regarding the advantages of self-treating the minor ailments with OTC medications such as paracetamol, thereby resulting in a higher rate of consumption. Increase in accessibility of e-Commerce platforms and online pharmacies is making it simpler for the consumers based in LAMEA to buy paracetamol, thereby boosting the market further. Request a Customized Copy of the Paracetamol Market Report @ (We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.) Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media? Email Directly Here with Detail Information: support@ Browse the full 'Paracetamol Market Size, Trends and Insights By Product Type (Tablet, Capsule, Liquid Suspension, Powder), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application Type (Headache & Fever, Muscle Cramps, Cold & Cough), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034' Report at List of the prominent players in the Paracetamol Market: Johnson & Johnson GlaxoSmithKline Pfizer Inc. Novartis AG Reddy's Laboratories Ltd. Aspen Pharmacare Adcock Ingram Julphar (Gulf Pharmaceutical Industries) Ache Laboratories Pharmaceutics EMS Pharma Hikma Pharmaceuticals Bharat Chemicals Farmson Pharmaceuticals SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation) Mylan N.V. (now part of Viatris) Others Click Here to Access a Free Sample Report of the Global Paracetamol Market @ Spectacular Deals Comprehensive coverage Maximum number of market tables and figures The subscription-based option is offered. Best price guarantee Free 35% or 60 hours of customization. Free post-sale service assistance. 25% discount on your next purchase. Service guarantees are available. Personalized market brief by author. Browse More Related Reports: US Surgical Instrument Tracking System Market: US Surgical Instrument Tracking Market Size, Trends and Insights By Technology (Barcodes, RFID), By Application (Hardware, Software, Services), By End-use (Hospitals, Ambulatory Surgical Centers), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025-2034 Digital Mammography Market: Digital Mammography Market Size, Trends and Insights By Technology (2D Full Field Digital Mammography, 3D Full Field Digital Mammography (Digital Breast Tomosynthesis), Contrast Enhanced Digital Mammography), By Product Type (Digital Mammography System, Display Unit, Central Processing Units, Visualization Software), By End-user (Hospitals and Surgical Centers, Breast Care Centers, Diagnostic Centers), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Lenacapavir Injection Market: Lenacapavir Injection Market Size, Trends and Insights By Indication (HIV Treatment, Pre-Exposure Prophylaxis (PrEP)), By Formulation (Injectable, Oral Tablets), By Distribution Channel (Branded Medicine, Generic Medicine), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Pharmaceutical Metal Detector Market: Pharmaceutical Metal Detector Market Size, Trends and Insights By Technology (Magnetic Field Detectors, Multi-frequency Detectors, X-Ray Inspection with Metal Detectors), By Application (Quality Control, Contaminant Detection, Packaging, Compliance), By End-user (Pharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), Biopharmaceutical Companies), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Deep Eutectic Solvents Market: Deep Eutectic Solvents Market Size, Trends and Insights By Product (Organic Salts + Metal Salts, Organic Salts + Metal Hydrates, Organic Salts + Hydrogen Bond Donor, Metal Chlorides + Hydrogen Bond Donor), By End-use (Pharmaceuticals & Healthcare, Food & Beverages Processing, Cosmetics & Personal Care, Chemical & Materials Industry), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025-2034 Medical Equipment Calibration Services Market: Medical Equipment Calibration Services Market Size, Trends and Insights By Service (In-house, Third-party Services, Original Equipment Manufacturers (OEMs)), By End-use (Hospitals, Clinical Laboratories), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 CRISPR and Cas Genes Market: CRISPR and Cas Genes Market Size, Trends and Insights By Technology Type (CRISPR/Cas9, CRISPR/Cas13, CRISPR/Cas14, Others), By Delivery Method (Ex vivo, In vivo, Physical Methods, Others), By Application Area (Functional Genomics, Oncology, Infectious Diseases, Others), By Tool Type (Guide RNA, CRISPR Plasmids, Cas Nucleases, Custom CRISPR Libraries, Vectors & Cloning Kits), By Crop Type (Cereals & Grains, Fruits & Vegetables, Oilseeds & Pulses, Industrial Crops), By Disease Type (Cancer, Blood Disorders, Ophthalmic Diseases, Infectious Diseases, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Y Chromosome Microdeletion Detection Kit Market: Y Chromosome Microdeletion Detection Kit Market Size, Trends and Insights By Product Type (PCR-based Kits, FISH-based Kits, Others), By Application (Hospitals, Diagnostic Laboratories, Research Institutes, Others), By End-User (Healthcare Providers, Research Laboratories, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 The Paracetamol Market is segmented as follows: By Product Type Tablet Capsule Liquid Suspension Powder By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies By Application Type Headache & Fever Muscle Cramps Cold & Cough Click Here to Get a Free Sample Report of the Global Paracetamol Market @ Regional Coverage: North America U.S. Canada Mexico Rest of North America Europe Germany France U.K. Russia Italy Spain Netherlands Rest of Europe Asia Pacific China Japan India New Zealand Australia South Korea Taiwan Rest of Asia Pacific The Middle East & Africa Saudi Arabia UAE Egypt Kuwait South Africa Rest of the Middle East & Africa Latin America Brazil Argentina Rest of Latin America This Paracetamol Market Research/Analysis Report Contains Answers to the following Questions. Which Trends Are Causing These Developments? Who Are the Global Key Players in This Paracetamol Market? What are Their Company Profile, Product Information, and Contact Information? What Was the Global Market Status of the Paracetamol Market? What Was the Capacity, Production Value, Cost and PROFIT of the Paracetamol Market? What Is the Current Market Status of the Paracetamol Industry? What's Market Competition in This Industry, Both Company and Country Wise? What's Market Analysis of Paracetamol Market by Considering Applications and Types? What Are Projections of the Global Paracetamol Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports? What Is Paracetamol Market Chain Analysis by Upstream Raw Materials and Downstream Industry? What Is the Economic Impact On Paracetamol Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends? What Are Market Dynamics of Paracetamol Market? What Are Challenges and Opportunities? What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Paracetamol Industry? Click Here to Access a Free Sample Report of the Global Paracetamol Market @ Reasons to Purchase Paracetamol Market Report Paracetamol Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors. Paracetamol Market report outlines market value (USD) data for each segment and sub-segment. This report indicates the region and segment expected to witness the fastest growth and dominate the market. Paracetamol Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region. The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled. Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players. The Industry's current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions. Paracetamol Market Includes in-depth market analysis from various perspectives through Porter's five forces analysis and provides insight into the market through Value Chain. Reasons for the Research Report The study provides a thorough overview of the global Paracetamol market. Compare your performance to that of the market as a whole. Aim to maintain competitiveness while innovations from established key players fuel market growth. Buy this Premium Paracetamol Research Report | Fast Delivery Available - [220+ Pages] @ What does the report include? Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide Paracetamol market analysis. The competitive environment of current and potential participants in the Paracetamol market is covered in the report, as well as those companies' strategic product development ambitions. According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions. For each segment mentioned above, actual market sizes and forecasts have been given. Who should buy this report? Participants and stakeholders worldwide Paracetamol market should find this report useful. The research will be useful to all market participants in the Paracetamol industry. Managers in the Paracetamol sector are interested in publishing up-to-date and projected data about the worldwide Paracetamol market. Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Paracetamol products' market trends. Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans. Request a Customized Copy of the Paracetamol Market Report @ About Custom Market Insights: Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. CMI provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey. Follow Us: LinkedIn | Twitter | Facebook | YouTube Contact Us: Joel John CMI Consulting LLC 1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702 USA: +1 737-734-2707 India: +91 20 46022736 Email: support@ Web: Blog: Blog: Blog: Blog: Buy this Premium Paracetamol Research Report | Fast Delivery Available - [220+ Pages] @ while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

South Korea pledges to help companies cope with higher US tariffs
South Korea pledges to help companies cope with higher US tariffs

Yahoo

time11 minutes ago

  • Yahoo

South Korea pledges to help companies cope with higher US tariffs

By Jihoon Lee SEOUL (Reuters) -South Korea will prepare measures to help companies cope with higher U.S. tariffs and expand into new markets, the Finance Ministry said on Tuesday, as it kicked off a task force to prepare the new administration's economic policy plans. On the domestic front, the government will come up with measures to boost short-term demand, as well as financial support for mid- to long-term technology development to enhance market competitiveness, it said in a statement. South Korea reached a trade deal with the U.S. last week, just days before President Donald Trump's threatened 25% tariff rate was due to come in on its exports to the United States. The trade deal set tariffs on exports from the Asian country at 15%, still higher than a baseline 10% rate and the near zero tariffs for exports under a Korea-U.S. free trade agreement. Still, topics left unresolved by the deal provide scope for more disputes as the two countries prepare for a summit between Trump and new South Korean President Lee Jae Myung in the coming weeks. Trump may use the summit to try to squeeze more concessions on areas such as defence costs and corporate investments, left out of the deal, while non-tariff barriers and currency could prove thorny issues, experts said. South Korea's Finance Ministry, however, sought to give a positive spin on the agreement. The deal reduced uncertainty over the trade environment, while a $350 billion investment package included in the deal will provide new business opportunities for companies, deepen economic cooperation between the two countries, and contribute to a more stable supply chain, the ministry said. The administration of President Lee also plans to prepare policy measures to foster new industries, such as artificial intelligence, semiconductors and "K-contents" and include them in economic growth strategies and budget plans due to be announced later this month. K-contents refers to a range of cultural and entertainment goods produced by the country ranging from K-pop to Korean dramas that have boomed globally. The ministry vowed to bring regulatory improvements to vitalise business activity, as it kicked off a meeting with the country's major business groups. Asia's fourth-largest economy grew in the second quarter at the fastest pace in more than a year on rebounding consumer spending and a surge in technology exports, but still faces headwinds from slowing global trade amid the sweeping tariffs. The International Monetary Fund last week raised its outlook for most advanced and emerging economies this year based on developments around U.S. tariff negotiations, but South Korea was among the exceptions, with its 2025 growth forecast revised down to 0.8% from 1.0%.

Trump Has Soured on Putin. Putin Couldn't Care Less.
Trump Has Soured on Putin. Putin Couldn't Care Less.

New York Times

time11 minutes ago

  • New York Times

Trump Has Soured on Putin. Putin Couldn't Care Less.

President Trump has not scared the Russian elite. Last week, he declared himself 'disappointed' with Vladimir Putin and imposed a shorter deadline — expiring this Friday — for an end to the war in Ukraine, threatening severe economic punishment if it was missed. In Moscow, no one took it seriously. After weathering more than three years of sanctions, the Kremlin believes it can handle anything thrown at it — that's if Mr. Trump even follows through, which many in Moscow doubt. But there's a deeper reason for the dismissive response. Mr. Putin has, according to Kremlin insiders I talked to, concluded that negotiating with the United States makes no sense and that compromise is pointless. Hostility, not friendship, is the policy. The imminent visit to Moscow of America's envoy for peace missions, Steve Witkoff, won't change that. Mr. Trump may have soured on Mr. Putin, but Russia's president couldn't care less. Six months ago, things were very different. When Mr. Trump returned to the presidency, many in Moscow hoped that a thaw in U.S.-Russia relations might be possible. Along with friendly public remarks from both presidents and negotiations in Saudi Arabia, there were other encouraging signs of détente. Russian propagandists refrained from criticizing the new American administration or Mr. Trump personally, apparently under orders from the Kremlin. (President Emmanuel Macron of France became the main target of attacks instead.) Soon, American businessmen began showing up in Moscow, calling themselves sponsors of Mr. Trump's campaign. They claimed that sanctions would be lifted and even that the president still dreamed of building a Trump Tower in Moscow. The Russian officials and entrepreneurs I spoke to were wary, but they wanted to believe that peace was possible and that Mr. Trump might persuade Mr. Putin to end the war. It seemed as if the dream of renewed cooperation with America might come true. It quickly became clear that this was wishful thinking. Everyone now realizes that Mr. Putin has no desire to end the war, which remains his main tool for controlling society. Worse, he has lost faith in the very idea of reaching agreements with the United States. According to the people I talked to, his view is that any American administration, by definition, is temporary — and so any deal with it is meaningless. Mr. Trump is in charge today, but in three years he might not be. Personal rapport means nothing. To Mr. Putin, it is no longer possible to build a working relationship with America. Kremlin propagandists sense the honeymoon is coming to an end. They're still avoiding direct attacks on Mr. Trump himself, but they're going after those around him. Senator Lindsey Graham, in particular, has been singled out as a 'Russophobic' extremist, especially after he suggested that Mr. Putin should 'call the Ayatollah' to ask what would happen on Day 51 after Mr. Trump's first ultimatum. On a recent episode of the flagship political talk show on the state-owned Russia-1, the host shouted into the camera: 'What are you croaking about? You'll be destroyed along with your America, and no one will even remember your name.' Want all of The Times? Subscribe.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store